Recommendation ID
NG228/03
Question

Nimodipine: What is the clinical and cost effectiveness of nimodipine in the management of aneurysmal subarachnoid haemorrhage?

Any explanatory notes
(if applicable)

For a short explanation of why the committee made this recommendation for research, see the rationale section on nimodipine.

Full details of the evidence and the committee's discussion are in evidence review D: medical management strategies.


Source guidance details

Comes from guidance
Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management
Number
NG228
Date issued
November 2022

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 30/11/2022